Xcout Intel
Monograph Capital
Monograph Capital is a life-sciences investment firm that provides venture capital to companies developing innovative therapeutics and related healthcare technologies. It works with entrepreneurs and management teams building businesses in the biotechnology and healthcare sectors.
Subscribe to see Monograph Capital’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Monograph Capital at a glance
Monograph Capital is a biotech company headquartered in United Kingdom. Xcout tracks 10 named people at Monograph Capital, including Mike LaGatta (Partner and COO). Xcout recorded 5 job postings from Monograph Capital in the last 90 days.
Monograph Capital leadership
- Mike LaGattaPartner and COO
- Daniel SchwarzChief Financial Officer
- Fred CohenPartner and Chairman
- Charles ConnPartner
- Tim FunnellPartner
- Jennifer ShahHead of Capital Formation
4 more named people on record for Monograph Capital, with roles, board committees and tenure — see the full roster →
Hiring at Monograph Capital
Xcout recorded 5 job postings from Monograph Capital in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Monograph Capital's hiring signals →
Monograph Capital competitors
A few of Monograph Capital's closest competitors — see the full list of competitors and alternatives →
Forbion is a European venture capital firm focused on life sciences, including biotechnology and medical technology. It manages investment funds and provides capital to innovative healthcare companies, primarily serving entrepreneurs and investors in the European life sciences sector.
Casdin Capital is an investment firm focused on the life sciences and healthcare sectors, including biotechnology, medical technology, and related companies. It serves institutional and other sophisticated investors through investment strategies targeting growth and innovation in healthcare.
Tachyon Ventures is a life-sciences venture capital firm that provides early-stage funding and smart capital to entrepreneurs and researchers in medicine, biotech, and bioengineering. The firm focuses on pre-Seed, Seed, and Series A investments in IP-backed, transformational scientific platforms.
RTW Venture Fund Limited primarily focuses on sourcing groundbreaking innovations poised for substantial growth within the biotechnology, pharmaceutical, and medical technology fields. The fund allocates capital to enterprises that are engineering advanced therapies and cutting-edge technologies, ultimately aiming to profoundly enhance patient quality of life.
Get Monograph Capital's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Monograph Capital? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Monograph Capital in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access